Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1

Clinical trial NCT05832931 · COMPLETED

Trial details

NCT number: NCT05832931
Sponsor: Pathalys Pharma
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism End-stage Kidney Disease (ESKD)

Start date: 2023-04-28
Primary completion: 2025-07-28
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.